The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2 targeted drugs: Results form the EUHER2 cohort study.
 
Julien Mazières
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly/ImClone; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech
Research Funding - Puma Biotechnology; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Thomas Filleron
No Relationships to Disclose
 
Benjamin Besse
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Isabelle Monnet
No Relationships to Disclose
 
Michele Beau-Faller
Honoraria - Boehringer Ingelheim; Roche Pharma AG
 
Solange Peters
No Relationships to Disclose
 
Eric Dansin
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Novartis; Pfizer; Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Roche Pharma AG
 
Martin Frueh
No Relationships to Disclose
 
Miklos Pless
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Novartis; Roche Pharma AG
 
Niki Karachaliou
No Relationships to Disclose
 
Marie Wislez
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Pierre Fournel
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); OSI Pharmaceuticals (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche
 
Virginie Westeel
No Relationships to Disclose
 
Federico Cappuzzo
Honoraria - Bristol-Myers Squibb; Pfizer; Roche Pharma AG
 
Alexis B. Cortot
Honoraria - AstraZeneca; Boehringer Ingelheim
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Lilly (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Expert Testimony - Boehringer Ingelheim; Lilly; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline; Lilly
 
Denis Moro-Sibilot
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly/ImClone; Novartis; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Lilly/ImClone; Pfizer; Roche/Genentech
 
Julie Milia
No Relationships to Disclose
 
Oliver Gautschi
No Relationships to Disclose